FDA and Belarus Sign Memorandum of Understanding to Facilitate U.S. Drug Registration in Belarus

Summary

The U.S. Food and Drug Administration (FDA) has signed a memorandum of understanding (MOU) with the Republic of Belarus to streamline the registration process for U.S. drugs and biological products in Belarus, aiming to enhance the country's healthcare sector.